wedge
Muscular Dystrophy Animal Models & CRO Services
Muscular Dystrophy Animal Models & CRO Services BIOTROFIX - Premier Preclinical CRO - Stroke, Alzheimer's, ALS, TBI Research - Seth P. Finklestein, M.D., CEO Muscular Dystrophy Animal Models & CRO Services Muscular Dystrophy Animal Models & CRO Services - CRO Preclinical Research
Muscular Dystrophy Animal Models & CRO Services Muscular Dystrophy Animal Models & CRO Services Muscular Dystrophy Animal Models & CRO Services Muscular Dystrophy Animal Models & CRO Services Muscular Dystrophy Animal Models & CRO Services
 
Home
greybar
The Company
greybar
Preclinical Research Services
PK/PD Studies
Acute Stroke
Stroke Recovery
Intracerebral Hemorrhage
Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Traumatic Brain Injury
Spinal Cord Injury
Muscular Dystrophy
Myocardial Infarction
Peripheral Vascular Disease
Others
Will Travel Services
greybar
The Team
greybar
News from Biotrofix
greybar
Publications
greybar
Contact Us


Well-equipped CRO laboratory
 

Muscular Dystrophy Animal Models & CRO Services

Muscular Dystrophy Animal Models & CRO Services The muscular dystrophies (MDs) are a group of inherited diseases causing progressive muscle wasting and weakness. Biotrofix is highly experienced with mouse models of MD (including Duchenne and Miyoshi dystrophies), including studies of drug and stem cell administration in these models. Endpoints of these studies are histological and functional (muscle strength).

 
 
Home | The Company | Preclinical Research Services | The Team | News | Publications | Contact Us | Site Map
wedgeBiotrofix, Inc. 604 Webster Street, Needham, MA 02494 Tel: 781-786-8890 Fax: 781-465-6061


Biotrofix is a premier preclinical contract research organization specializing in animal models of CNS, cardiac and vascular disease. With years of experience, both academic, commercial, clients throughout the biotech and pharmaceutical industries, Biotrofix delivers industry-leading preclinical CRO services, including rodent models of acute stroke and stroke recovery, preclinical CRO services for Alzheimer's Disease, transgenic animal models for ALS, as well as CRO services for brain injury, preclinical CRO services for spinal cord injury and related cardiac drug discovery and development.